Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting drugs to APJ receptor: From signaling to pathophysiological effects
Zhen Huang, Lu He, Zhe Chen, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 1, pp. 61-74
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Apelin/APJ system: an emerging therapeutic target for respiratory diseases
Jialong Yan, Aiping Wang, Jiangang Cao, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 15, pp. 2919-2930
Closed Access | Times Cited: 86
Advances in the therapeutic potentials of ligands of the apelin receptor APJ
Gerry T. M. Wagenaar, Gert N. Moll
European Journal of Pharmacology (2025), pp. 177302-177302
Open Access | Times Cited: 1
Apelin/APJ system: A potential therapeutic target for endothelial dysfunction‐related diseases
Jun Cheng, Xuling Luo, Zhen Huang, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 8, pp. 12149-12160
Closed Access | Times Cited: 50
Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
Pamela Senesi, Livio Luzi, Ileana Terruzzi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8372-8372
Open Access | Times Cited: 48
The apelin/APJ system as a therapeutic target in metabolic diseases
Isabelle Castan‐Laurell, Bernard Masri, Philippe Valet
Expert Opinion on Therapeutic Targets (2018) Vol. 23, Iss. 3, pp. 215-225
Closed Access | Times Cited: 47
The role of endothelial cell in cardiac hypertrophy: Focusing on angiogenesis and intercellular crosstalk
Xing Yang, Kun Cheng, Lu-Yun Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114799-114799
Open Access | Times Cited: 13
The regulatory role of the apelin/APJ axis in scarring: Identification of upstream and downstream mechanisms
Nian Shi, Yi Wang, Zhenyu Xia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 4, pp. 167125-167125
Open Access | Times Cited: 4
Function and regulation of apelin/APJ system in digestive physiology and pathology
Zhen Huang, Xuling Luo, Meiqing Liu, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 7796-7810
Closed Access | Times Cited: 37
The therapeutic potentials of apelin in obesity-associated diseases
Isabelle Castan‐Laurell, Cédric Dray, Philippe Valet
Molecular and Cellular Endocrinology (2021) Vol. 529, pp. 111278-111278
Open Access | Times Cited: 26
A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide
Roberto Monastero, Daniele Magro, Marika Venezia, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102076-102076
Open Access | Times Cited: 9
A patent review of apelin receptor (APJR) modulators (2014-2019)
Conrad Fischer
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 4, pp. 251-261
Closed Access | Times Cited: 23
Constraining the Side Chain of C-Terminal Amino Acids in Apelin-13 Greatly Increases Affinity, Modulates Signaling, and Improves the Pharmacokinetic Profile
Kien Trân, Robin Van Den Hauwe, Xavier Sainsily, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 9, pp. 5345-5364
Open Access | Times Cited: 18
Design and preclinical evaluation of a novel apelin-based PET radiotracer targeting APJ receptor for molecular imaging of angiogenesis
Béatrice Louis, Vincent Nail, Oriane Nachar, et al.
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 463-475
Open Access | Times Cited: 7
Apelinergic system in the kidney: implications for diabetic kidney disease
Tilman Müller, Anastasia Z. Kalea, Alonso Márquez, et al.
Physiological Reports (2018) Vol. 6, Iss. 23, pp. e13939-e13939
Open Access | Times Cited: 20
The emerging role of the apelinergic system in kidney physiology and disease
Peter Janssens, Jean-Paul Decuypere, Bert Bammens, et al.
Nephrology Dialysis Transplantation (2021) Vol. 37, Iss. 12, pp. 2314-2326
Open Access | Times Cited: 15
Apelin/APJ system: A novel therapeutic target for locomotor system diseases
Jingshun Luo, Wei Liu, Fen Feng, et al.
European Journal of Pharmacology (2021) Vol. 906, pp. 174286-174286
Closed Access | Times Cited: 15
Elabela promotes the retinal angiogenesis by inhibiting ferroptosis during the vaso‐obliteration phase in mouse oxygen‐induced retinopathy model
Jianhui Wang, Qi Zhang, Enguang Chen, et al.
The FASEB Journal (2022) Vol. 36, Iss. 5
Closed Access | Times Cited: 11
DNMT1 mediates proliferation, migration and invasion of extravillous trophoblasts by regulating the methylation level of APLNR
Yan Zhou, Xiaoyan Zhang, Zhuan Liu, et al.
Placenta (2023) Vol. 138, pp. 33-43
Closed Access | Times Cited: 6
PEGylated and Acylated Elabela Analogues Show Enhanced Receptor Binding, Prolonged Stability, and Remedy of Acute Kidney Injury
Chao Wang, Mingrui Xiong, Chen Yang, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 16028-16042
Closed Access | Times Cited: 16
A network map of apelin-mediated signaling
Shobha Dagamajalu, Rex Devasahayam Arokia Balaya, Pushparani Devi Philem, et al.
Journal of Cell Communication and Signaling (2021) Vol. 16, Iss. 1, pp. 137-143
Open Access | Times Cited: 14
Apelin receptor upregulation in spontaneously hypertensive rat contributes to the enhanced vascular smooth muscle cell proliferation by activating autophagy
Tao Xu, Jian Jia, Na Xu, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 8, pp. 627-627
Open Access | Times Cited: 13
Protective effect of Huashi Baidu formula against AKI and active ingredients that target SphK1 and PAI-1
Yute Zhong, Xia Du, Ping Wang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Half-life extension of peptidic APJ agonists by N-terminal lipid conjugation
Anthony B. Reed, Brian A. Lanman, Jerry Ryan Holder, et al.
Bioorganic & Medicinal Chemistry Letters (2020) Vol. 30, Iss. 21, pp. 127499-127499
Closed Access | Times Cited: 10
A Novel Peptide Elabela is Associated with Hypertension-Related Subclinical Atherosclerosis
Hendrianus, Suko Adiarto, Radityo Prakoso, et al.
High Blood Pressure & Cardiovascular Prevention (2022) Vol. 30, Iss. 1, pp. 37-44
Closed Access | Times Cited: 6
Critical APJ receptor residues in extracellular domains that influence effector selectivity
Anisha Ashokan, Harikumar Sheela Harisankar, Mythili Kameswaran, et al.
FEBS Journal (2021) Vol. 288, Iss. 22, pp. 6543-6562
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top